Connect your AI

Upstream Bio, Inc. UPB Total Assets

Total Assets at other companies

AmgenAMGN

$92.5B+3.5%

Regeneron PharmaceuticalsREGN

$40.87B+8.9%

Aclaris TherapeuticsACRS

$198.72M+0.3%

Shattuck Labs, Inc.STTK

$102.12M+32.3%

SavaraSVRA

$221.65M+17.1%

AnaptysBio, Inc.ANAB

$329.68M-21.9%

Other financials

Income statement

Revenue$1.0M+82.7%

Operating income-$43.6M-36.2%

Net income-$40.6M-48.8%

EPS (diluted)-$0.75-47.1%

Balance sheet

Cash & equivalents$96.7M+35.6%

Total debt$1.1M-34.5%

Total equity$304.0M-31.8%

Cash flow

Operating cash flow-$47.9M-16.2%

CapEx$54.0K-70.8%

Free cash flow-$30.7M-55.0%

Valuation

Market cap$346.11M-40.9%

Enterprise value$250.5M-51.4%

P/S104.2×-151×

Profitability

Operating margin-5,176.5%+1,764pp

Net margin-4,719%+2,752pp

Returns & leverage

Return on equity-41.8%—

Debt / equity0×0.0×

Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Upstream Bio, Inc.'s total assets?: Upstream Bio, Inc. (UPB) reported total assets of $318.05M in Q1 2026.
How has Upstream Bio, Inc.'s total assets changed year-over-year?: Upstream Bio, Inc.'s total assets decreased by 30.3% year-over-year, from $456.17M to $318.05M.
What is the long-term trend for Upstream Bio, Inc.'s total assets?: Over 2 years (2023 to 2025), Upstream Bio, Inc.'s total assets has grown at a 73.7% compound annual growth rate (CAGR), from $117.2M to $353.77M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.